SCOPUS 정보 검색 플랫폼

Current Therapeutic Research - Clinical and Experimental

Volumn 60, Issue 3, 1999, Pages 138-144

Pilot study of divalproex sodium versus valproic acid: Drug acquisition costs versus all related costs

(1) Brasfield, Kenneth H a,b,c

a Western State Hospital Staunton (United States)

b VIRGINIA COMMONWEALTH UNIVERSITY (United States)

c UNIVERSITY OF VIRGINIA (United States)

Author keywords

Cost benefit analysis; Divalproex sodium; Economics; Gastroenteritis; Mental disorders; Valproic acid

Indexed keywords

ALUMINUM MAGNESIUM HYDROXIDE; CISAPRIDE; GAVISCON; KAOLIN PECTIN; RANITIDINE; VALPROATE SEMISODIUM; VALPROIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DELIRIUM; DRUG COATING; DRUG COST; DRUG FORMULATION; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; SCHIZOIDISM; SCHIZOPHRENIA; SEIZURE;

EID: 0033000055 PISSN: 0011393X EISSN: None Source Type: Journal
DOI: 10.1016/S0011-393X(00)88522-7 Document Type: Article

Times cited : (10)

References (10)

1
- 0043109661
- Montvale, NJ: Medical Economics Co
- Depakene®, Depakote® Sprinkle, and Depakote®. Physicians' Desk Reference®. 50th Ed. Montvale, NJ: Medical Economics Co; 1996:413-418.
- (1996) Physicians' Desk Reference®. 50th Ed. , pp. 413-418

2
- 0020539960
- Gastrointestinal tolerance of divalproex sodium
- Wilder BJ, Karas BJ, Penry JK, et al. Gastrointestinal tolerance of divalproex sodium. Neurology. 1983;33:808-811.
- (1983) Neurology , vol.33 , pp. 808-811
- Wilder, B.J.¹ Karas, B.J.² Penry, J.K.³

3
- 85030354105
- Abbott Park, Ill: Abbott Laboratories; February
- Depakene® Package Insert. Abbott Park, Ill: Abbott Laboratories; February 1995.
- (1995) Depakene® Package Insert

4
- 0018860194
- Bioavailability of valproic acid under fasting/nonfasting regimens.
- Chun AHC, Hoffman DJ, Friedmann N, et al. Bioavailability of valproic acid under fasting/nonfasting regimens. J Clin Pharmacol. 1980;20:30-36.
- (1980) J Clin Pharmacol , vol.20 , pp. 30-36
- Chun, A.H.C.¹ Hoffman, D.J.² Friedmann, N.³

5
- 85030354981
- Abbott Park, Ill: Abbott Laboratories; August
- Bioavailability Data, F83-103. Abbott Park, Ill: Abbott Laboratories; August 1995.
- (1995) Bioavailability Data, F83-103

6
- 0024990386
- Absorption characteristics of a new valproate formulation: Divalproex sodium coated particles in capsules (Depakote® Sprinkle)
- Carrigan PJ, Brinker DR, Cavanaugh JH, et al. Absorption characteristics of a new valproate formulation: Divalproex sodium coated particles in capsules (Depakote® Sprinkle). J Clin Pharmacol. 1990;30:743-747.
- (1990) J Clin Pharmacol , vol.30 , pp. 743-747
- Carrigan, P.J.¹ Brinker, D.R.² Cavanaugh, J.H.³

7
- 0023730142
- Gastritis with valproate therapy
- Marks WA, Morris MP, Bodensteiner JB, et al. Gastritis with valproate therapy. Arch Neurol. 1988;45:903-905.
- (1988) Arch Neurol , vol.45 , pp. 903-905
- Marks, W.A.¹ Morris, M.P.² Bodensteiner, J.B.³

8
- 0018340755
- Gastroesophageal reflux among severely retarded children
- Sondheimer JM, Morris BA, Gastroesophageal reflux among severely retarded children. J Pediatr. 1979;94:710-714.
- (1979) J Pediatr , vol.94 , pp. 710-714
- Sondheimer, J.M.¹ Morris, B.A.²

9
- 0013612145
- Divalproex sodium: Cost effective alternative in long-term care
- Smart JR. Divalproex sodium: Cost effective alternative in long-term care. Consult Pharmacist. 1995;10:533-538.
- (1995) Consult Pharmacist , vol.10 , pp. 533-538
- Smart, J.R.¹

10
- 0030877909
- Clinical and economic impact of replacing divalproex sodium with valproic acid
- Cranor CW, Sawyer WT, Carson SW, et al. Clinical and economic impact of replacing divalproex sodium with valproic acid. Am J Health-Syst Pharm. 1997;54:1716-1722.
- (1997) Am J Health-Syst Pharm , vol.54 , pp. 1716-1722
- Cranor, C.W.¹ Sawyer, W.T.² Carson, S.W.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.